Roche prevails in EU patent dispute:
This article was originally published in Clinica
A district court in Germany has ruled that Roche Diagnostics' LightCycler Factor V kit, used to detect gene mutations that causes a blood-clotting condition known as thrombophilia, has not infringed on Instrumentation Labs', which holds an exclusive licence to European patent 0 690 991, filed the lawsuit in July last year. The company has been given the option to appeal the decision.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.